These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8911290)

  • 1. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.
    Sergeant MD; Hodgetts PG; Godwin M; Walker DM; McHenry P
    CMAJ; 1996 Nov; 155(9):1243-8. PubMed ID: 8911290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
    Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
    Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
    Gülöksüz S; Oral ET; Ulaş H
    Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention.
    Randall ML; Rosenbaum JR; Rohrbaugh RM; Rosenheck RA
    Acad Psychiatry; 2005; 29(1):33-9. PubMed ID: 15772402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical policies in Canadian family medicine training. Survey of residency programs.
    Mahood S; Zagozeski C; Bradel T; Lawrence K
    Can Fam Physician; 1997 Nov; 43():1947-51. PubMed ID: 9386881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policies regulating the activities of pharmaceutical representatives in residency programs.
    Brotzman GL; Mark DH
    J Fam Pract; 1992 Jan; 34(1):54-7. PubMed ID: 1728655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical industry support and residency education: a survey of internal medicine program directors.
    Loertscher LL; Halvorsen AJ; Beasley BW; Holmboe ES; Kolars JC; McDonald FS
    Arch Intern Med; 2010 Feb; 170(4):356-62. PubMed ID: 20177039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical abortion and family physicians. Survey of residents and practitioners in two Ontario settings.
    Raymond E; Kaczorowski J; Smith P; Sellors J; Walsh A
    Can Fam Physician; 2002 Mar; 48():538-44. PubMed ID: 11935718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice guidelines. New-to-practice family physicians' attitudes.
    Ferrier BM; Woodward CA; Cohen M; Williams AP
    Can Fam Physician; 1996 Mar; 42():463-8. PubMed ID: 8616286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice choices of graduating family medicine residents.
    Godwin M; Hodgetts G; Wilson R; Pong R; Najgebauer E
    Can Fam Physician; 1998 Mar; 44():532-6. PubMed ID: 9559193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
    Misra S; Ganzini L; Keepers G
    Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge of medical-legal issues. Survey of Ontario family medicine residents.
    Saltstone SP; Saltstone R; Rowe BH
    Can Fam Physician; 1997 Apr; 43():669-73. PubMed ID: 9111983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
    CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structured approach to pharmaceutical representatives. Family medicine residency program.
    Kelcher S; Brownoff R; Meadows LM
    Can Fam Physician; 1998 May; 44():1053-6, 1059-60. PubMed ID: 9612591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
    Razack S; Arbour L; Hutcheon R
    Ann R Coll Physicians Surg Can; 1999 Mar; 32(2):93-6. PubMed ID: 12378718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.